Advisor - Lab Automation Scientist at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Ph.D. in Bioengineering, Biomedical Engineering, Chemical Engineering, Mechanical Engineering or related discipline with at least 2 years of industry experience (following post-doctorate), or M.S. in Bioengineering, Biomedical Engineering, Chemical Engineering, Mechanical Engineering or related discipline with a minimum of 10 years of automation engineer-specific experience, or B.S. in Bioengineering, Biomedical Engineering, Chemical Engineering, Mechanical Engineering or related discipline with a minimum of 13 years of automation engineer-specific experience
Relevant industry experience in a well-equipped automation lab, preferably in a pharmaceutical company or an automation provider
Proficiency in the operation, maintenance, troubleshooting and optimization of liquid handlers (Beckman, Hamilton, HighRes, Lynx etc.), micro-dispensers (BioTek, Thermo, Formulatrix, etc.), microplate washers and readers, high throughput antibody quantification instruments, and E. coli colony plating/picking (QPix)
Hands-on expertise in the operation, maintenance, troubleshooting and optimization of integrated automation workstations

Responsibilities

Ensure that common lab automation equipment (stand-alone liquid handlers/micro-dispensers, plate readers/washers, protein quantification instruments, colony/plaque pickers, sequencing instruments etc., as well as fully integrated robotic systems) is maintained in good working order
Work closely with automation engineers on installing, maintaining, and qualifying automation equipment, developing operational scripts, updating scheduling software, and providing support to non-automation scientists throughout the site
Work collaboratively with protein discovery, engineering, and protein expression groups at the San Diego site to optimize research efficiencies through implementation of novel automation process improvements and technologies
Collaborate with external vendors and internal teams to design, implement, and validate new automation equipment, integrated robotic workstations, lab digitalization technologies, autonomous laboratory automation systems, and closed-loop learning solutions

Skills

Lab Automation

Liquid Handlers

Plate Readers

Protein Quantification

Colony Pickers

Sequencing Instruments

Robotic Systems

Data Analysis

Laboratory Software

Biotherapeutics

High-throughput Screening

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free